Published in AJNR Am J Neuroradiol on March 19, 2015
Assessment of serial multi-parametric functional MRI (diffusion-weighted imaging and R2*) with (18)F-FDG-PET in patients with head and neck cancer treated with radiation therapy. Br J Radiol (2015) 0.81
Evaluation of Head and Neck Tumors with Functional MR Imaging. Magn Reson Imaging Clin N Am (2016) 0.79
Functional MRI for the prediction of treatment response in head and neck squamous cell carcinoma: potential and limitations. Cancer Imaging (2016) 0.78
The emerging potential of magnetic resonance imaging in personalizing radiotherapy for head and neck cancer: an oncologist's perspective. Br J Radiol (2017) 0.76
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72
Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging (1999) 13.26
Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A (2005) 4.63
Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A (2005) 3.15
Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma. J Clin Oncol (2010) 2.90
The parametric response map is an imaging biomarker for early cancer treatment outcome. Nat Med (2009) 2.32
A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol (2009) 2.10
Oropharyngeal cancer: current understanding and management. Curr Opin Otolaryngol Head Neck Surg (2009) 1.31
End points for new agents in induction chemotherapy for locally advanced head and neck cancers. Ann Oncol (2002) 1.16
The promise of dynamic contrast-enhanced imaging in radiation therapy. Semin Radiat Oncol (2011) 1.12
An approach to identify, from DCE MRI, significant subvolumes of tumors related to outcomes in advanced head-and-neck cancer. Med Phys (2012) 1.02
Squamous cell carcinoma of the oropharynx and hypopharynx. Otolaryngol Clin North Am (2005) 0.93
Reproducibility of the gadolinium concentration measurements and of the fitting parameters of the vascular input function in the superior sagittal sinus in a patient population. Magn Reson Imaging (2010) 0.89
Post-treatment imaging of head and neck cancer. Cancer Imaging (2004) 0.88
Head and neck cancer. Med Clin North Am (2010) 0.86
Utility of pretreatment mean apparent diffusion coefficient and apparent diffusion coefficient histograms in prediction of outcome to chemoradiation in head and neck squamous cell carcinoma. J Comput Assist Tomogr (2012) 0.85
Carcinoma of the oral pharynx: an analysis of subsite treatment heterogeneity. Surg Oncol Clin N Am (2004) 0.83